SCHEMBL9640914

SCHEMBL9640914

CC(C)(C)OC(=O)C(C)(C)O/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[n+]3ccccc3)CS[C@H]12)c1csc(N)n1

nearest known ligand 0.89

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR1I2 O75469 4/20 0.89
▸ ESR1 P03372 2/20 0.89
▸ PPARG P37231 2/20 0.89
▸ PGR P06401 1/20 0.89
▸ TDP1 Q9NUW8 7/20 0.88
▸ HSD17B10 Q99714 4/20 0.88
▸ ADRA1A P35348 1/20 0.60
▸ MAPT P10636 5/20 0.59
▸ APEX1 P27695 3/20 0.59
▸ ALDH1A1 P00352 2/20 0.59
▸ POLB P06746 2/20 0.59
▸ RECQL P46063 2/20 0.59
▸ CYP1A2 P05177 1/20 0.59
▸ PKM P14618 1/20 0.59
▸ ABCC4 O15439 1/20 0.59
▸ LMNA P02545 1/20 0.59
▸ NPSR1 Q6W5P4 1/20 0.59
▸ L3MBTL1 Q9Y468 1/20 0.59
▸ DRD2 P14416 1/20 0.58
▸ ADRA2B P18089 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL9343404 0.95 NR1I2 (0.80) NR1I2ESR1PPARGPGRTDP1
Water SCHEMBL9343390 0.95 NR1I2 (0.80) NR1I2ESR1PPARGPGRTDP1
SCHEMBL30366963 0.95 NR1I2 (0.91) NR1I2ESR1PPARGPGRTDP1
Ceftazidime SCHEMBL10746412 0.94 NR1I2 (1.00) NR1I2ESR1PPARGPGRTDP1
Ceftazidime SCHEMBL27816764 0.94 NR1I2 (1.00) NR1I2ESR1PPARGPGRTDP1
Ceftazidime SCHEMBL10746421 0.94 NR1I2 (1.00) NR1I2ESR1PPARGPGRTDP1
Ceftazidime SCHEMBL36850 0.94 NR1I2 (1.00) NR1I2ESR1PPARGPGRTDP1
Ceftazidime SCHEMBL10678530 0.94 NR1I2 (1.00) NR1I2ESR1PPARGPGRTDP1
Ceftazidime SCHEMBL36849 0.94 NR1I2 (1.00) NR1I2ESR1PPARGPGRTDP1
Ceftazidime SCHEMBL1625852 0.94 NR1I2 (1.00) NR1I2ESR1PPARGPGRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0282531-B1 STABLE CRYSTALLINE FORM OF AN INTERMEDIATE PRODUCT OF CEPHALOSPORINE BIOCHEMIE GESELLSCHAFT M.B.H. (AT) 1992-04-15 — — EP claimed
Send feedback